Chinese vaccine gets approval from O BSH for mass use

The World Health Organization approved the Chinese vaccine against Coronavirus, Sinovac, for emergency use.

This is the first vaccine developed in a non-Western country to receive WHO approval.

China has already vaccinated several million people with this vaccine, while it has been distributed to dozens of other countries.

Green light from O The BSH is a guide for national regulators that the vaccine is safe and effective.

Some health regulators, especially in the poorest countries in Africa, Latin America, and Asia, have already approved the Chinese vaccine.

But approval from O BSH means that vaccine can also be used in the global Covax programme, which aims to provide about two billion vaccines for developing countries.

So far, Covax has distributed about 50 million doses of vaccines -- 24,000 in Kosovo as well.

One of the main advantages of Sinovac vaccine is that it can be preserved in a standard refrigerator, at 2 degrees Celsius, just like the Anglo-Swedian company AztraZeneca vaccine.

By comparison, the vaccine of the American producer Pfizer and the German man, BioNTech, must be preserved at ultra cold temperatures: -70 degrees Celsius.

Tests of the Sinovac vaccine in Brazil have shown that its efficiency is 50.4 percent above the 50% threshold, which is needed for approval by WHO.

Other tests in Turkey and Indonesia, however, have shown a higher degree of efficiency.